{'52WeekChange': 0.052222252,
 'SandP52WeekChange': 0.0644362,
 'address1': '57 West 57th Street',
 'address2': 'Manhattan',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 9.5,
 'askSize': 1300,
 'averageDailyVolume10Day': 76475,
 'averageVolume': 60790,
 'averageVolume10days': 76475,
 'beta': -0.365826,
 'beta3Year': None,
 'bid': 9.29,
 'bidSize': 1800,
 'bookValue': -0.063,
 'category': None,
 'circulatingSupply': None,
 'city': 'New York',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 10.32,
 'dayLow': 9,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -42.02,
 'enterpriseToRevenue': None,
 'enterpriseValue': 198487040,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 9.540857,
 'fiftyTwoWeekHigh': 16.5,
 'fiftyTwoWeekLow': 2.5,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 6829016,
 'forwardEps': -2,
 'forwardPE': -4.735,
 'fromCurrency': None,
 'fullTimeEmployees': 17,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.6801,
 'heldPercentInstitutions': 0.00033,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1585612800,
 'lastMarket': None,
 'lastSplitDate': 1575504000,
 'lastSplitFactor': '1:10',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/nemauramedical.com',
 'longBusinessSummary': 'Nemaura Medical Inc., a medical technology company, '
                        'discovers, develops, and commercializes diagnostic '
                        'medical devices. The company provides sugarBEAT, a '
                        'non-invasive continuous glucose monitoring device for '
                        'use by persons with Type I and Type II diabetes, as '
                        'well as for screening pre-diabetic patients. Nemaura '
                        'Medical Inc. was founded in 2009 and is based in New '
                        'York, New York.',
 'longName': 'Nemaura Medical Inc.',
 'market': 'us_market',
 'marketCap': 198510144,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_261156471',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -4160196,
 'nextFiscalYearEnd': 1648684800,
 'open': 10.04,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '646 416 8000',
 'previousClose': 9.73,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 10.32,
 'regularMarketDayLow': 9,
 'regularMarketOpen': 10.04,
 'regularMarketPreviousClose': 9.73,
 'regularMarketPrice': 10.04,
 'regularMarketVolume': 61000,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 20808300,
 'sharesPercentSharesOut': 0.0054,
 'sharesShort': 112370,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 20231,
 'shortName': 'Nemaura Medical Inc.',
 'shortPercentOfFloat': 0.0165,
 'shortRatio': 0.99,
 'startDate': None,
 'state': 'NY',
 'strikePrice': None,
 'symbol': 'NMRD',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.2,
 'twoHundredDayAverage': 6.278748,
 'volume': 61000,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://nemauramedical.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '10019'}